Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/01/2022 03:00

Jan 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              271.43              234.93           360.00    
                   (+15.5 pct)         (+4.3 pct)       (+16.4 pct) 
  Operating           82.17               82.19           107.00    
                   (+0.0 pct)          (+24.4 pct)      (+8.8 pct)  
  Pretax              84.35               84.66           109.00    
                   (-0.4 pct)          (+23.3 pct)      (+8.0 pct)  
  Net                 64.62               66.49            83.00    
                   (-2.8 pct)          (+28.3 pct)      (+10.0 pct) 
  EPS Basic        129.61 yen          133.20 yen       166.47 yen  
  EPS Diluted      129.59 yen          133.19 yen                   
  Ann Div                               50.00 yen        56.00 yen  
  -Q2 Div           28.00 yen           22.50 yen                   
  -Q4 Div                               27.50 yen        28.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T